Growing evidence demonstrates that appropriate functional antagonism of PPARγ/RXR ameliorates fatty liver, which may be a logical approach to protection against obesity and related diseases25,53,54. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.